“Identification of New Quinazolinone-Based Inhibitors with Submicromolar Potency for IP6K1 Using High-Throughput Screening”

https://pubmed.ncbi.nlm.nih.gov/38116421

A high-throughput screening approach has led to the identification of new quinazolinone-based inhibitors with submicromolar potency for inositol hexakisphosphate kinase 1 (IP6K1), exhibiting interesting selectivity over other IP6K isoforms.